Drug-eluting Stents Current Events | Drug-eluting Stents News | 2
|
| Page
2 of
29 |
571 Results |
|
|
|
Sort By:
Page Views | Date |
Study confirms that stents releasing medication help keep heart bypass vein grafts open
Stents can be inserted into a grafted vein or into a native coronary artery during a balloon angioplasty procedure. view more (2005-12-02)
SPIRIT IV trial shows everolimus stent sets new standard for event-free survival
Late-breaking data from SPIRIT IV, a large-scale multi-center study of nearly 4,000 patients in the U.S., shows that an everolimus-eluting stent demonstrated enhanced safety and efficacy in the treatment of de novo native coronary artery lesions when compared to a paclitaxel-eluting stent, and showed that "low late loss" may be achieved... view more... (2009-09-24)
Treatment of severe coronary artery disease with drug-eluting stents a viable alternative to CABG
Severe stenosis (blockage) to the left main coronary artery-a condition commonly called a "widow-maker"- can result in sudden death. view more (2006-02-28)
ESC Congress 2003: Advocating the use of drug-eluting stents in all patients with coronary disease
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Drug-eluting stents - a universal panacea Coronary artery disease... view more... (2003-09-02)
Drug-eluting stents better than bare-metal stents for heart attack patients
Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the... view more... (2009-09-28)
Olive oil emulsion helps with problem heart arteries
An emulsion of olive oil, egg yolk and glycerine might be just the recipe to keep heart patients away from the operating room and cardiac bypass surgery. view more (2006-12-19)
Value of stent-coating drugs questioned
Patients admitted to the hospital with acute coronary syndromes (ACS) are often treated with a catheter-based procedure known as percutaneous coronary intervention (PCI), during which a stent is inserted into an occluded or narrowed coronary artery to restore blood flow to and from the heart. view more (2007-03-27)
Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 9-12,... view more... (2007-05-18)
SCAAR registry provides reassurance on drug eluting stent safety
A study published today in The New England Journal of Medicine (May 7, 2009) (1), analysed the outcomes of 47,967 patients entered into the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) between 2003 and 2006. view more (2009-05-07)
Fast release of data leads to rapid changes in clinical practice for drug-eluting stents
E-mail, search engines, smart phones and other new technologies that can disseminate new medical information quickly led to an almost immediate change in clinical practice for drug-eluting stents, according to a study reported in Circulation: Cardiovascular Quality and Outcomes. view more (2009-07-29)
ESC Congress 2003: In whom submitted to a percutaneous coronary intervention could we avoid stenting?
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Drug-eluting stents - a universal panacea A stent is a... view more... (2003-09-02)
Desensitization protocol overcomes allergy to clopidogrel
A careful desensitization protocol can help patients overcome allergic reactions to anti-clotting medication critical to preventing new blockages inside coronary stents. view more (2006-05-12)
Mayo Clinic researchers use magnetic attraction to improve stents, reduce blood clot risk
Mayo Clinic heart researchers have devised a new strategy to improve the effectiveness and safety of heart stents, which are used to open narrowed blood vessels and have been the recent subject of clotting concerns. view more (2006-11-03)
Experts debate role of stenting, bypass surgery in left main coronary artery disease
Coronary artery bypass surgery has been the preferred treatment for patients with a blockage in the left main coronary artery, the conduit that supplies blood to about two-thirds of the heart. view more (2007-05-14)
Potential treatment option for severe emphysema under study
Emory University researchers are participating in a nationwide study to explore an investigational treatment for advanced widespread emphysema. view more (2008-09-25)
Researchers at Pulmonary Associates to study airway bypass procedure for severe emphysema
Researchers at Pulmonary Associates today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a new, minimally invasive option for those suffering with advanced widespread emphysema. view more (2008-02-12)
New type of sirolimus-eluting stent demonstrates superior results
A new type of sirolimus-eluting stent (SES) successfully showed significantly greater neointimal suppression than the paclitaxel-eluting stent (PES) with greater vessel wall integrity surrounding the stent, confirming the finding of superiority of the SES over the PES stent for the trial's primary endpoint of in-stent late loss. view more (2009-09-22)
The Lancet publishes first clinical trial data of a fully bioabsorbable drug eluting stent
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac... view more... (2008-03-14)
Patients who receive drug-eluting stents should continue antiplatelet medications
Patients who have had drug-eluting stents inserted to prop open blocked coronary arteries should continue to take medications to reduce the risk of blood clots for at least one year after the stent is inserted, a new scientific advisory recommends. view more (2007-01-17)
SCAI issues clinical alert on drug-eluting stents and late thrombosis
The Society for Cardiovascular Angiography and Interventions (SCAI) today released a clinical alert advising physicians on practical steps for reducing the risk of a rare but serious complication associated with the use of drug-eluting stents. view more (2007-01-11)
|
|
| Page
2 of
29 |
571 Results |
|
|
|
Sort By:
Page Views | Date |
|
